{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T15:10:00Z","timestamp":1791817800817,"version":"4.3.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T00:00:00Z","timestamp":1597622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T00:00:00Z","timestamp":1597622400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s00403-020-02127-5","type":"journal-article","created":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T04:03:21Z","timestamp":1597637001000},"page":"473-482","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Characteristics of hospitalized dermatomyositis patients with underlying malignancy: a nationally representative retrospective cohort study"],"prefix":"10.1007","volume":"313","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8545-6781","authenticated-orcid":false,"given":"Raghav","family":"Tripathi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony P.","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,17]]},"reference":[{"issue":"489","key":"2127_CR1","first-page":"241","volume":"53","author":"G Stertz","year":"1916","unstructured":"Stertz G (1916) Polymyositis. Berl Klin Wochenschr 53(489):241\u2013266","journal-title":"Berl Klin Wochenschr"},{"issue":"4","key":"2127_CR2","doi-asserted-by":"publisher","first-page":"e94128","DOI":"10.1371\/journal.pone.0094128","volume":"9","author":"X Lu","year":"2014","unstructured":"Lu X, Yang H, Shu X et al (2014) Factors predicting malignancy in patients with polymyositis and dermatomyostis: a systematic review and meta-analysis. Kuwana M, ed. PLoS ONE 9(4):e94128. https:\/\/doi.org\/10.1371\/journal.pone.0094128","journal-title":"PLoS ONE"},{"issue":"3","key":"2127_CR3","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1056\/NEJM199207163270318","volume":"327","author":"Risk of Cancer in Dermatomyositis or Polymyositis","year":"1992","unstructured":"Risk of Cancer in Dermatomyositis or Polymyositis (1992) N Engl J Med 327(3):207\u2013208. https:\/\/doi.org\/10.1056\/NEJM199207163270318","journal-title":"N Engl J Med"},{"issue":"9250","key":"2127_CR4","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/S0140-6736(00)03540-6","volume":"357","author":"CL Hill","year":"2001","unstructured":"Hill CL, Zhang Y, Sigurgeirsson B et al (2001) Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet 357(9250):96\u2013100. https:\/\/doi.org\/10.1016\/S0140-6736(00)03540-6","journal-title":"Lancet"},{"key":"2127_CR5","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3899\/jrheum.140566","volume":"42","author":"Z Yang","year":"2015","unstructured":"Yang Z, Lin F, Qin B, Liang Y, Zhong R (2015) Polymyositis\/Dermatomyositis and Malignancy Risk: A Metaanalysis Study. J Rheumatol 42:282\u2013291. https:\/\/doi.org\/10.3899\/jrheum.140566","journal-title":"J Rheumatol"},{"issue":"2","key":"2127_CR6","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s40257-015-0120-1","volume":"16","author":"JM Olazagasti","year":"2015","unstructured":"Olazagasti JM, Baez PJ, Wetter DA, Ernste FC (2015) Cancer risk in dermatomyositis: a meta-analysis of cohort studies. Am J Clin Dermatol 16(2):89\u201398. https:\/\/doi.org\/10.1007\/s40257-015-0120-1","journal-title":"Am J Clin Dermatol"},{"key":"2127_CR7","unstructured":"Healthcare Cost and Utilization Project (HCUP) HCUP National Inpatient Sample (NIS). Agency for Healthcare Research and Quality, Rockville, MD. www.hcup-us.ahrq.gov\/nisoverview.jsp. Accessed 1 Aug 2018"},{"key":"2127_CR8","unstructured":"National Center for Health Statistics (NCHS) (2013) ICD-9-CM: International Classification of Diseases, Ninth Revision, Clinical Modification. Baltimore, MD: U.S. National Library of Medicine; 2013. https:\/\/www.nlm.nih.gov\/research\/umls\/sourcereleasedocs\/current\/ICD9CM\/metadata.html. Accessed 1 Aug 2018"},{"issue":"5","key":"2127_CR9","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1002\/acr.23010","volume":"69","author":"MC Kwa","year":"2017","unstructured":"Kwa MC, Ardalan K, Laumann AE, Nardone B, West DP, Silverberg JI (2017) Validation of international classification of diseases codes for the epidemiologic study of dermatomyositis. Arthritis Care Res (Hoboken) 69(5):753\u2013757. https:\/\/doi.org\/10.1002\/acr.23010","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"4","key":"2127_CR10","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1093\/rheumatology\/kex465","volume":"57","author":"JI Silverberg","year":"2018","unstructured":"Silverberg JI, Kwa L, Kwa MC, Laumann AE, Ardalan K (2018) Cardiovascular and cerebrovascular comorbidities of juvenile dermatomyositis in US children: an analysis of the National Inpatient Sample. Rheumatology 57(4):694\u2013702. https:\/\/doi.org\/10.1093\/rheumatology\/kex465","journal-title":"Rheumatology"},{"issue":"7","key":"2127_CR11","doi-asserted-by":"publisher","first-page":"e0175508","DOI":"10.1371\/journal.pone.0175508","volume":"12","author":"W-Q Wei","year":"2017","unstructured":"Wei W-Q, Bastarache LA, Carroll RJ et al (2017) Evaluating phecodes, clinical classification software, and ICD-9-CM codes for phenome-wide association studies in the electronic health record. Rzhetsky A. ed. PLoS ONE 12(7):e0175508. https:\/\/doi.org\/10.1371\/journal.pone.0175508","journal-title":"PLoS ONE"},{"key":"2127_CR12","unstructured":"HCUP (2016) Appendix A: Clinical Classification Software-Diagnoses. AHRQ. https:\/\/www.hcup-us.ahrq.gov\/toolssoftware\/ccs\/AppendixASingleDX.txt. Published 2016. Accessed 24 March 2016"},{"key":"2127_CR13","unstructured":"Healthcare Cost and Utilization Project (2018) HCUP-US Tools and Software Page CCS-Services and Procedures. AHRQ. https:\/\/www.hcup-us.ahrq.gov\/toolssoftware\/ccs_svcsproc\/ccssvcproc.jsp#details. Published 2015. Accessed 3 Oct 2018"},{"key":"2127_CR14","unstructured":"Bureau of Labor Statistics. Consumer Price Index Inflation Calculator. Databases, Tables, and Calculators. https:\/\/www.bls.gov\/data\/inflation_calculator.htm."},{"issue":"2","key":"2127_CR15","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.jid.2017.08.039","volume":"138","author":"DY Hsu","year":"2018","unstructured":"Hsu DY, Shinkai K, Silverberg JI (2018) Epidemiology of eczema herpeticum in hospitalized U.S. children: analysis of a nationwide cohort. J Invest Dermatol. 138(2):265\u2013272. https:\/\/doi.org\/10.1016\/j.jid.2017.08.039","journal-title":"J Invest Dermatol."},{"key":"2127_CR16","unstructured":"Di Rollo D, Abeni D, Tracanna M, Capo A, Amerio P (2014) Cancer risk in dermatomyositis: a systematic review of the literature. G Ital Dermatol Venereol. 149(5):525\u2013537. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24975953. Accessed 25 July 2018"},{"issue":"5","key":"2127_CR17","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.bjoms.2009.08.025","volume":"48","author":"D Chapireau","year":"2010","unstructured":"Chapireau D, Adlam D, Cameron M, Thompson M (2010) Paraneoplastic syndromes in patients with primary oral cancers: a systematic review. Br J Oral Maxillofac Surg 48(5):338\u2013344. https:\/\/doi.org\/10.1016\/j.bjoms.2009.08.025","journal-title":"Br J Oral Maxillofac Surg"},{"issue":"2","key":"2127_CR18","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1097\/MD.0b013e31819da352","volume":"88","author":"L Fardet","year":"2009","unstructured":"Fardet L, Dupuy A, Gain M et al (2009) Factors associated with underlying malignancy in a retrospective cohort of 121 patients with dermatomyositis. Medicine (Baltimore) 88(2):91\u201397. https:\/\/doi.org\/10.1097\/MD.0b013e31819da352","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"2127_CR19","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s00296-003-0319-y","volume":"23","author":"C Botsios","year":"2003","unstructured":"Botsios C, Ostuni P, Boscolo-Rizzo P, Da Mosto MC, Punzi L, Marchiori C (2003) Dermatomyositis and malignancy of the pharynx in Caucasian patients: report of two observations. Rheumatol Int 23(6):309\u2013311. https:\/\/doi.org\/10.1007\/s00296-003-0319-y","journal-title":"Rheumatol Int"},{"key":"2127_CR20","doi-asserted-by":"crossref","unstructured":"Buchbinder R, Forbes A, Hall S, Dennett X, Giles G (2001) Incidence of malignant disease in biopsy-proven inflammatory myopathy. A population-based cohort study. Ann Intern Med 134(12):1087\u20131095. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11412048. Accessed 30 Jan 2019","DOI":"10.7326\/0003-4819-134-12-200106190-00008"},{"issue":"12","key":"2127_CR21","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1002\/hed.23821","volume":"37","author":"DC Ling","year":"2015","unstructured":"Ling DC, Kabolizadeh P, Heron DE et al (2015) Incidence of hospitalization in patients with head and neck cancer treated with intensity-modulated radiation therapy. Head Neck 37(12):1750\u20131755. https:\/\/doi.org\/10.1002\/hed.23821","journal-title":"Head Neck"},{"issue":"19","key":"2127_CR22","doi-asserted-by":"publisher","first-page":"e3403","DOI":"10.1097\/MD.0000000000003403","volume":"95","author":"H-S Kang","year":"2016","unstructured":"Kang H-S, Roh J-L, Lee S-W et al (2016) Noncancer-Related Health Events and Mortality in Head and Neck Cancer Patients After Definitive Radiotherapy: A Prospective Study. Medicine (Baltimore) 95(19):e3403. https:\/\/doi.org\/10.1097\/MD.0000000000003403","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"2127_CR23","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1093\/annonc\/mdu128","volume":"25","author":"M Kwon","year":"2014","unstructured":"Kwon M, Roh J-L, Song J et al (2014) Noncancer health events as a leading cause of competing mortality in advanced head and neck cancer. Ann Oncol 25(6):1208\u20131214. https:\/\/doi.org\/10.1093\/annonc\/mdu128","journal-title":"Ann Oncol"},{"issue":"1","key":"2127_CR24","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1002\/hed.23703","volume":"37","author":"AH Adi","year":"2015","unstructured":"Adi AH, Alturkmani H, Spock T et al (2015) Dermatomyositis paraneoplastic syndrome before symptomatic tonsillar squamous cell carcinoma: A case report. Anderson P, ed. Head Neck 37(1):E1\u2013E3. https:\/\/doi.org\/10.1002\/hed.23703","journal-title":"Head Neck"},{"issue":"2","key":"2127_CR25","first-page":"147","volume":"49","author":"KD Bertakis","year":"2000","unstructured":"Bertakis KD, Azari R, Helms LJ, Callahan EJ, Robbins JA (2000) Gender differences in the utilization of health care services. J Fam Pract 49(2):147\u2013152","journal-title":"J Fam Pract"},{"issue":"10","key":"2127_CR26","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1001\/jamadermatol.2014.635","volume":"150","author":"S Shen","year":"2014","unstructured":"Shen S, Wolfe R, McLean CA, Haskett M, Kelly JW (2014) Characteristics and associations of high-mitotic-rate melanoma. JAMA Dermatol 150(10):1048. https:\/\/doi.org\/10.1001\/jamadermatol.2014.635","journal-title":"JAMA Dermatol"},{"key":"2127_CR27","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.abb.2014.06.018","volume-title":"Sex disparities in melanoma outcomes: the role of biology","author":"A Nosrati","year":"2014","unstructured":"Nosrati A, Wei ML (2014) Sex disparities in melanoma outcomes: the role of biology, vol 563. Academic Press Inc., Cambridge, pp 42\u201350 https:\/\/doi.org\/10.1016\/j.abb.2014.06.018"},{"issue":"8","key":"2127_CR28","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1001\/jamadermatol.2013.4408","volume":"149","author":"CS Gamba","year":"2013","unstructured":"Gamba CS, Clarke CA, Keegan THM, Tao L, Swetter SM (2013) Melanoma survival disadvantage in young, non-hispanic white males compared with females. JAMA Dermatol 149(8):912. https:\/\/doi.org\/10.1001\/jamadermatol.2013.4408","journal-title":"JAMA Dermatol"},{"issue":"1","key":"2127_CR29","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/BF00051675","volume":"6","author":"W-H Chow","year":"1995","unstructured":"Chow W-H, Gridley G, Mellemkj\u00e6r L, McLaughlin JK, Olsen JH, Fraumeni JF (1995) Cancer risk following polymyositis and dermatomyositis: a nationwide cohort study in Denmark. Cancer Causes Control 6(1):9\u201313. https:\/\/doi.org\/10.1007\/BF00051675","journal-title":"Cancer Causes Control"},{"issue":"1","key":"2127_CR30","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1001\/archdermatol.2009.328","volume":"146","author":"MJ Bendewald","year":"2010","unstructured":"Bendewald MJ, Wetter DA, Li X, Davis MDP (2010) Incidence of dermatomyositis and clinically amyopathic dermatomyositis. Arch Dermatol 146(1):26\u201330. https:\/\/doi.org\/10.1001\/archdermatol.2009.328","journal-title":"Arch Dermatol"},{"issue":"1","key":"2127_CR31","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.jaad.2018.01.002","volume":"79","author":"L Kooistra","year":"2018","unstructured":"Kooistra L, Ricotti C, Galimberti F, Gota C, Fernandez AP (2018) Malignancy-associated dermatomyositis: retrospective case\u2013control study from a single tertiary care center. J Am Acad Dermatol 79(1):152\u2013155. https:\/\/doi.org\/10.1016\/j.jaad.2018.01.002","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"2127_CR32","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1001\/jamadermatol.2015.5240","volume":"152","author":"D Hsu","year":"2016","unstructured":"Hsu D, Brieva J, Silverberg JI (2016) Costs of care for hospitalization for pemphigus in the United States. JAMA Dermatology 152(6):645. https:\/\/doi.org\/10.1001\/jamadermatol.2015.5240","journal-title":"JAMA Dermatology"},{"issue":"2","key":"2127_CR33","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.urology.2014.09.053","volume":"85","author":"JD Sammon","year":"2015","unstructured":"Sammon JD, McKay RR, Kim SP et al (2015) Burden of hospital admissions and utilization of hospice care in metastatic prostate cancer patients. Urology 85(2):343\u2013350. https:\/\/doi.org\/10.1016\/j.urology.2014.09.053","journal-title":"Urology"},{"issue":"3","key":"2127_CR34","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1002\/lary.22447","volume":"122","author":"CG Gourin","year":"2012","unstructured":"Gourin CG, Frick KD (2012) National trends in oropharyngeal cancer surgery and the effect of surgeon and hospital volume on short-term outcomes and cost of care. Laryngoscope 122(3):543\u2013551. https:\/\/doi.org\/10.1002\/lary.22447","journal-title":"Laryngoscope"},{"key":"2127_CR35","doi-asserted-by":"crossref","unstructured":"Kono H, Inokuma S, Nakayama H, Suzuki M (2000) Pneumomediastinum in dermatomyositis: association with cutaneous vasculopathy. Ann Rheum Dis 59(5):372\u2013376. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10784520. Accessed 26 July 2018","DOI":"10.1136\/ard.59.5.372"},{"issue":"2","key":"2127_CR36","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.jaad.2019.05.105","volume":"82","author":"R Waldman","year":"2020","unstructured":"Waldman R, DeWane ME, Lu J (2020) Dermatomyositis: diagnosis and treatment. J Am Acad Dermatol 82(2):283\u2013296. https:\/\/doi.org\/10.1016\/j.jaad.2019.05.105","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"2127_CR37","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1002\/art.33379","volume":"64","author":"E Trallero-Aragu\u00e1s","year":"2012","unstructured":"Trallero-Aragu\u00e1s E, Rodrigo-Pend\u00e1s J\u00c1, Selva-O\u2019Callaghan A et al (2012) Usefulness of anti-p155 autoantibody for diagnosing cancer-associated dermatomyositis: A systematic review and meta-analysis. Arthritis Rheum 64(2):523\u2013532. https:\/\/doi.org\/10.1002\/art.33379","journal-title":"Arthritis Rheum"},{"issue":"3","key":"2127_CR38","doi-asserted-by":"publisher","first-page":"256","DOI":"10.2340\/00015555-3091","volume":"99","author":"M Best","year":"2019","unstructured":"Best M, Molinari N, Chasset F, Vincent T, Cordel N, Bessis D (2019) Use of anti-transcriptional intermediary factor-1 gamma autoantibody in identifying adult dermatomyositis patients with cancer: a systematic review and meta-analysis. Acta Derm Venereol 99(3):256\u2013262. https:\/\/doi.org\/10.2340\/00015555-3091","journal-title":"Acta Derm Venereol"},{"issue":"11","key":"2127_CR39","doi-asserted-by":"publisher","first-page":"2954","DOI":"10.1002\/art.38093","volume":"65","author":"DF Fiorentino","year":"2013","unstructured":"Fiorentino DF, Chung LS, Christopher-Stine L et al (2013) Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1\u03b3. Arthritis Rheum 65(11):2954\u20132962. https:\/\/doi.org\/10.1002\/art.38093","journal-title":"Arthritis Rheum"},{"key":"2127_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-017-1469-8","author":"H Yang","year":"2017","unstructured":"Yang H, Peng Q, Yin L et al (2017) Identification of multiple cancer-associated myositis-specific autoantibodies in idiopathic inflammatory myopathies: a large longitudinal cohort study. Arthritis Res Ther. https:\/\/doi.org\/10.1186\/s13075-017-1469-8","journal-title":"Arthritis Res Ther."},{"key":"2127_CR41","doi-asserted-by":"publisher","first-page":"205031211878189","DOI":"10.1177\/2050312118781895","volume":"6","author":"CH Lim","year":"2018","unstructured":"Lim CH, Tseng C-W, Lin C-T et al (2018) The clinical application of tumor markers in the screening of malignancies and interstitial lung disease of dermatomyositis\/polymyositis patients: a retrospective study. SAGE Open Med 6:205031211878189. https:\/\/doi.org\/10.1177\/2050312118781895","journal-title":"SAGE Open Med"},{"issue":"6","key":"2127_CR42","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1097\/BOR.0000000000000535","volume":"30","author":"A Selva-O\u2019Callaghan","year":"2018","unstructured":"Selva-O\u2019Callaghan A, Martinez-G\u00f3mez X, Trallero-Aragu\u00e1s E, Pinal-Fern\u00e1ndez I (2018) The diagnostic work-up of cancer-associated myositis. Curr Opin Rheumatol. 30(6):630\u2013636. https:\/\/doi.org\/10.1097\/BOR.0000000000000535","journal-title":"Curr Opin Rheumatol."}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-020-02127-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-020-02127-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-020-02127-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T23:40:03Z","timestamp":1629157203000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-020-02127-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,17]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["2127"],"URL":"https:\/\/doi.org\/10.1007\/s00403-020-02127-5","relation":{},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"value":"0340-3696","type":"print"},{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,17]]},"assertion":[{"value":"11 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.P.F. is an investigator for Pfizer, Corbus, Mallinckrodt, and Novartis pharmaceuticals. He receives personal research support from Mallinckrodt and Novartis; honorarium from AbbVie, UCB, Novartis, and Mallinckrodt for consulting and advisory board participation, and honorarium from AbbVie, Novartis and Mallinckrodt for teaching and speaking. R.T. reports no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"By request.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"IRB approval was not necessary for use of this publicly available, de-identified database.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}